A61K35/58

HOMEOPATHIC COMPLEX
20220288205 · 2022-09-15 ·

The present invention is directed to a homeopathic complex for use in the treatment of various diseases or disorders, including use as an anti-infective agent and/or in the regeneration of diseased or damaged tissue. Ideally, the anti-infective homeopathic complex of the invention may comprise a homeopathic tincture or dilutions thereof of Hepar sulphuris calcareum or other similar profiled Calcarea or Sulphur salt or acid, Lachesis muta or other remedy with a similar profile, Mercurius Solubilis or similar mercury containing remedy and Silica or other silica containing compounds.

HOMEOPATHIC COMPLEX
20220288205 · 2022-09-15 ·

The present invention is directed to a homeopathic complex for use in the treatment of various diseases or disorders, including use as an anti-infective agent and/or in the regeneration of diseased or damaged tissue. Ideally, the anti-infective homeopathic complex of the invention may comprise a homeopathic tincture or dilutions thereof of Hepar sulphuris calcareum or other similar profiled Calcarea or Sulphur salt or acid, Lachesis muta or other remedy with a similar profile, Mercurius Solubilis or similar mercury containing remedy and Silica or other silica containing compounds.

Purification of Reptilian Hyaluronic Acid and Its Use for Soft and Hard Tissue Repair and Regeneration
20220289869 · 2022-09-15 ·

An ultra-rapid method for the isolation and purification of high molecular weight hyaluronic acid (HA) from the skin of reptiles (rHA). The method utilizes an extraction buffer that inhibits unwanted hyaluronidases, filtration to remove cell debris and precipitated proteins, and a highly substituted anion exchange column at a low pH with a high salt elution to maximize the yield and purity of rHA per kilogram of skin. rHA is extremely charged and elutes between 1.6-3M NaCl. Our findings suggest that rHA is high molecular weight (>2 mDa) and has a profound ability to enhance cell migration and proliferation for wound repair and regeneration. Preliminary evidence suggests that scaffolds of rHA are ideal for biomaterial engineering that could be incorporated into several medical devices and pharmaceutical products. We have identified novel crosslinking methods to streamline esterification of rHA for advanced wound care products as well as novel conjugates to improve the osteogenic and osteoconductive potential of rHA for bone regeneration and repair.

Homeopathic complex
11298421 · 2022-04-12 ·

The present invention is directed to a homeopathic complex for use in the treatment of various diseases or disorders, including use as an anti-infective agent and/or in the regeneration of diseased or damaged tissue. Ideally, the anti-infective homeopathic complex of the invention may comprise a homeopathic tincture or dilutions thereof of Hepar sulphuris calcareum or other similar profiled Calcarea or Sulphur salt or acid, Lachesis muta or other remedy with a similar profile, Mercurius Solubilis or similar mercury containing remedy and Silica or other silica containing compounds.

Homeopathic complex
11298421 · 2022-04-12 ·

The present invention is directed to a homeopathic complex for use in the treatment of various diseases or disorders, including use as an anti-infective agent and/or in the regeneration of diseased or damaged tissue. Ideally, the anti-infective homeopathic complex of the invention may comprise a homeopathic tincture or dilutions thereof of Hepar sulphuris calcareum or other similar profiled Calcarea or Sulphur salt or acid, Lachesis muta or other remedy with a similar profile, Mercurius Solubilis or similar mercury containing remedy and Silica or other silica containing compounds.

Homeopathic complex
11298421 · 2022-04-12 ·

The present invention is directed to a homeopathic complex for use in the treatment of various diseases or disorders, including use as an anti-infective agent and/or in the regeneration of diseased or damaged tissue. Ideally, the anti-infective homeopathic complex of the invention may comprise a homeopathic tincture or dilutions thereof of Hepar sulphuris calcareum or other similar profiled Calcarea or Sulphur salt or acid, Lachesis muta or other remedy with a similar profile, Mercurius Solubilis or similar mercury containing remedy and Silica or other silica containing compounds.

Composition and methods for treating bone and joint disease including extract from crocodilos reptilia and herbs

The method includes treating bone and joint diseases with a composition which includes collagen, essential minerals, and mineral lactate which were derived from the bones of crocodilos reptilia (crocodile). Crocodile collagen is made of a different ratio of amino acids than mammalian collagen which may be at least partly responsible for its therapeutic properties. The composition further includes a mixture of herbs. The mixture of herbs may include Clinacanthus nutans, Eclipta prostrata, Drynaria rhizome, and Auricularia polytricha. The herbs in the mixture of herbs each has one or more of the following properties: anti-inflammatory, analgesic, bone formation enhancement, and increases the number of osteoblast proliferation without impacting the number or activity of osteoclasts. The composition may also include essential minerals which are important for bone formation. This composition may be useful to treat or prevent several common bone or joint diseases including osteoporosis, arthritis, and osteogenesis imperfecta.

nAChR-alpha7 Agonists and nAChR-alpha7 Antagonists for Treating Ulcerative Colitis (UC) and Crohn's Disease (CD)
20210177816 · 2021-06-17 ·

Agonists and antagonists of nAChRα7 and their use as therapeutic agents for treating and managing inflammatory bowel diseases (IBD), such as Crohn's disease (CD) and ulcerative colitis (UC), are disclosed.

nAChR-alpha7 Agonists and nAChR-alpha7 Antagonists for Treating Ulcerative Colitis (UC) and Crohn's Disease (CD)
20210177816 · 2021-06-17 ·

Agonists and antagonists of nAChRα7 and their use as therapeutic agents for treating and managing inflammatory bowel diseases (IBD), such as Crohn's disease (CD) and ulcerative colitis (UC), are disclosed.

Hydrogel toxin-absorbing or binding nanoparticles

The present invention provides for compositions comprising a polymeric hydrogel impregnated with a toxin-absorbing or binding nanoparticle. The present invention also provides for the use of the above compositions for decreasing or neutralizing the effect of a toxin, or for treating or preventing an infection by a microbe that produces a toxin, in a subject. The exemplary toxin is a biological toxin such as a viral, bacterial, fungal, plant or animal toxin.